Connect Sign In
ARUP’s Robert Ohgami, MD, PhD, MBA, FCAP, gave a poster presentation detailing novel research on AI-driven grading of Castleman disease histopathology. |
December 8, 2025 | ARUP Experts Contributed to Castleman Disease Research Showcased by Recordati at ASH Annual Meeting BRIDGEWATER, N.J.—Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders characterized by abnormal lymph node enlargement and systemic inflammatory symptoms that can be potentially life threatening. |
The RESULTS Act would block looming cuts in payments for lab testing services and protect patients’ access to essential lab tests. |
November 19, 2025 | ARUP Advocates for the RESULTS Act To Protect Patient Access to Critical Laboratory Testing Services The RESULTS Act offers meaningful reform to a flawed system and will ultimately benefit patients, support innovation, and create stability within the clinical laboratory community. |
Blaine Mathison, BS, M(ASCP), technical director of Parasitology at ARUP, reviews digital images of wet-mount slides. Mathison played a significant role in the validation of the AI screening tool for the detection of gastrointestinal parasites. |
October 21, 2025 | Journal of Clinical Microbiology Publishes Article on ARUP’s Validation of AI for Parasite Detection An article describing ARUP’s validation of an artificial intelligence (AI) solution to detect gastrointestinal parasites in wet mounts has been published in the Journal of Clinical Microbiology. |
|
September 15, 2025 | ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program ARUP is the largest lab to receive reaccreditation under the updated ISO 15189 standard, an achievement that highlights the company’s technical excellence, commitment to quality, and innovation. |
The biomarker pTau 217 is associated with Alzheimer’s disease pathology and can be detected in plasma, providing a minimally invasive option to support other diagnostic tests. |
April 21, 2025 | ARUP Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathology ARUP Laboratories now offers a test for pTau 217 to aid in the detection of Alzheimer’s disease pathology. This test is minimally invasive and more accessible than other types of diagnostic testing. |
The U.S. District Court for the Eastern District of Texas today struck down the FDA’s final rule to regulate laboratory-developed tests. |
March 31, 2025 | ARUP Applauds Federal Court Decision Vacating the FDA’s Final Rule Regulating Lab-Developed Tests The rule and its compliance deadlines are no longer in effect, benefiting patient care, innovation, and the greater laboratory community, ARUP leaders said. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
Press Releases
Live Chat